The current 0Y3M market cap is 788.3M. The company's latest EPS is USD -2.2730 and P/E is -5.73.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 853k | 200.58M | 53.91M | 91.37M | 135.16M |
Operating Income | -112.73M | 71.98M | -131.56M | -191.04M | -128.93M |
Net Income | -111.14M | 66.98M | -116.95M | -147.03M | -122.31M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 332.98M | 609.37M | 758.04M | 696.38M | 547.11M |
Total Liabilities | 148.97M | 143.32M | 135.99M | 135.02M | 60.18M |
Total Equity | 184.01M | 466.04M | 622.04M | 561.37M | 486.93M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -80.36M | 92.61M | -108.82M | -133.91M | N/A |
Investing | -196k | -575k | -464k | -2.77M | N/A |
Financing | 215k | 190.33M | 241.46M | 45.1M | N/A |
Market Cap | 788.3M |
Price to Earnings Ratio | -5.73 |
Price to Sales Ratio | 5.19 |
Price to Cash Ratio | 1.49 |
Price to Book Ratio | 1.44 |
Dividend Yield | - |
Shares Outstanding | 53.81M |
Average Volume (1 week) | 211 |
Average Volume (1 Month) | 524 |
52 Week Change | 0.00% |
52 Week High | 14.65 |
52 Week Low | 14.65 |
Spread (Intraday) | 0 (0%) |
Company Name | Prothena Corporation Plc |
Address |
77 sir john rogerson’s quay dublin D02 VK60 |
Website | https://www.prothena.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions